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To examine the association between maternal BMI>50kg/m2 during pregnancy and mater-
nal and perinatal outcomes.
Materials and methods
An international cohort study was conducted using data from separate national studies in
the UK and Australia. Outcomes of pregnant women with BMI>50 were compared to those
of pregnant women with BMI<50. Multivariable logistic regression estimated the association
between BMI>50 and perinatal and maternal outcomes.
Results
932 pregnant women with BMI>50 were compared with 1232 pregnant women with
BMI<50. Pregnant women with BMI>50 were slightly older, more likely to be multiparous,
and have pre-existing comorbidities. There were no maternal deaths, however, extremely
obese women had a nine-fold increase in the odds of thrombotic events compared to those
with a BMI<50 (uOR: 9.39 (95%CI:1.15–76.43)). After adjustment, a BMI>50 during preg-
nancy had significantly raised odds of preeclampsia/eclampsia (aOR:4.88(95%CI: 3.11–
7.65)), caesarean delivery (aOR: 2.77 (95%CI: 2.31–3.32)), induction of labour (aOR: 2.45
(95% CI:2.00–2.99)) post caesarean wound infection (aOR:7.25(95%CI: 3.28–16.07)),
macrosomia (aOR: 8.05(95%CI: 4.70–13.78)) compared a BMI<50. Twelve of the infants
born to women in the extremely obese cohort died in the early neonatal period or were
stillborn.
Conclusions
Pregnant women with BMI>50 have a high risk of inferior maternal and perinatal outcomes.
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Introduction
Obesity, defined as a BMI >30kg/m2, has been shown to be associated with a number of poor
perinatal and maternal outcomes such as hypertensive disorders, metabolic disorders, iatro-
genic intervention and poor perinatal outcomes including macrosomia, prematurity and still-
birth [1, 2]. As obesity in pregnancy affects a substantial proportion of women, it is estimated
16% of pregnant women have a BMI>30 in the UK, the related complications and conditions
represent a significant public health problem [3].
There is a growing body of evidence examining super obesity or extreme obesity in preg-
nancy, defined as a BMI�50 kg/m2 at any point during pregnancy [4–8]. These studies have
shown that pregnant women with BMI�50 kg/m2 compared to pregnant women with lower
BMIs are at an increased risk of multiple adverse maternal and perinatal outcomes. Due to the
relatively low prevalence of BMI�50 in pregnancy these studies have had either been com-
pleted over a long period of time or on a national basis to include a sample size sufficient to
allow precise estimates of effect. Despite a number of national studies examining pregnant
women with BMI�50 they have been limited in their ability to examine severe but rare mater-
nal and perinatal outcomes such as thrombotic events and perinatal deaths. Meta-analysis of
observational studies is often limited by heterogeneity of populations and measures used
across studies. The opportunities to combine data from separate studies completed in different
countries are infrequent due to differences in data collection methods and incomparability.
The aim of this study was to examine maternal and perinatal outcomes in pregnant women
with BMI of>50 from the UK and Australia.
Materials and methods
Study population and design
This was a collaborative international population-based cohort study using secondary data
analysis of two national studies undertaken in Australia and the United Kingdom [6, 8]. The
exposed cohort in this study was pregnant women with BMI>50 and the comparison (unex-
posed) cohort were those with a BMI<50 kg/m2. The definitions were harmonised for the pur-
poses of this analysis to include women who had a BMI>50 at any point during pregnancy,
see Fig 1.
In each nation, data were collected using national obstetric surveillance systems namely,
the United Kingdom Obstetric Surveillance System (UKOSS) and the Australasian Maternity
Outcomes Surveillance System (AMOSS). The respective methodologies of each surveillance
systems has been explained in detail elsewhere [8–10]. Information about pregnant women
with BMI>50 was collected from consultant-led obstetric centres in the UK and from hospitals
with over 50 births per year in Australia, using the respective national case definitions (box 1).
These are the units in which these women are likely to be delivered.
Fig 1. Definitions used to identify the cohorts by country.
https://doi.org/10.1371/journal.pone.0211278.g001
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The UK comparison cohort was identified as the women who delivered in the same unit
immediately before the women with BMI>50 but whose BMI was lower. The same question-
naire was used to collect data from both groups of women. Australia’s comparison cohort was
identified from data collected in two different AMOSS studies (placenta accreta and peripar-
tum hysterectomy) as the two women delivering immediately prior to the identified cases of
placenta accreta or peripartum hysterectomy, and who had a BMI<50 kg/m2. In the Australian
study, a general questionnaire was used to collect data about both the comparison and
extremely obese groups, while the extremely obese group had an additional tailored question-
naire. All data were collected anonymously.
Data and data collection
Covariates, outcomes and management variables relevant to the research question were
identified a priori guided by literature review. These desired variables were then included in
the analysis if they were available in both datasets. A mapping exercise assessed the compara-
bility of variables between the AMOSS and UKOSS data collection forms. Variables where
coding or definitions differed were harmonised if a common definition or coding could
be found. Variables where no common definition could be found were excluded from the
analysis these included socioeconomic status, gestational diabetes, admission to an intensive
therapy unit and postpartum haemorrhage. Ethnicity was not available in the Australian
dataset.
Covariates available for analysis were age, smoking status during pregnancy, previous preg-
nancy problems, pre-existing medical problems, pre-existing hypertension, parity and multiple
pregnancy. Management and outcomes collected were those recorded in the hospital records’
of the woman. Management and maternal outcomes assessed in this study were hypertensive
disorders during pregnancy, induction of labour, caesarean delivery, post-caesarean wound
infection and thrombotic event. Perinatal outcomes explored were perinatal death, stillbirth
(>24weeks gestation), preterm birth (<37 weeks), very preterm birth (<32 weeks), birth-
weight, macrosomia (birthweight�4500 grams), congenital abnormality, infant respiratory
problem and Apgar score <7 at 5 minutes.
Previous studies using UKOSS data have shown that the distribution of missing data for
each variable was not missing at random; as a result multiple imputation was not considered
appropriate [11]. For each category of a variable, a proxy category was used to report the miss-
ing data for that variable. In a sensitivity analysis, complete case analysis was used to assess the
impact of using proxy variables.
The sample size was predetermined by the size of the existing studies; therefore the sample
was fixed at 932 pregnant women with BMI>50 and 1232 pregnant women with BMI<50. For
the lowest frequency outcome (stillbirth), which had an incidence of 8 per 1000 in the unex-
posed group, given the sample size the minimum detectable odds ratio with 80% power at the
5% statistical significance level was 3.55 or greater. For the highest frequency outcome, which
had an incidence of 26.9% (caesarean delivery) in the unexposed group, the minimum detect-
able odds ratio with 80% power at the 5% significance level was 1.31 or greater.
Statistical analysis
Difference in characteristics between those who had a BMI>50 and those with a BMI<50
were assessed using Chi Square tests or Wilcoxon rank sum tests. Each outcome was individu-
ally modelled using an unconditional logistic regression model, presented as odds ratios with
95% confidence intervals. To account for clustering of infants within mothers’ with multiple
birth, robust estimates of variance were calculated for perinatal outcomes [12]. Collinearity
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was assessed between all plausible linear associations prior to multivariable analysis, using
Pearson’s correlation coefficient.
Only outcomes that were statistically significant at the univariable level were included in
the multivariable analysis. A forward stepwise modelling strategy was used to sequentially add
potential covariates to the univariable model; results were examined after the addition of each
variable. A covariate was included in the final model if it significantly improved the fit of the
data as assessed by likelihood ratio tests at the 5% significance level. STATA V.13 was used to
complete statistical analysis (STATA CORP, Texas, USA).
In an additional sensitivity analysis, the comparison group was also restricted to pregnant
women who had a BMI<30 to assess the impact on the magnitude of identified associations in
the multivariable analysis.
Ethics committee approval
Approval for the obtained secondary use of Australia data obtained was from the Human Re-
search Ethics Committee (HREC) (Ref no. HREC/09/CIPHF/21), New South Wales, Australia.
Ethics committee approval for secondary analysis of anonymous data was not required in the UK.
Results
During the period September 2007-August 2008, 617 pregnant women with BMI>50 kg/m2
were identified through the UK Obstetric Surveillance System. Between January—October
2010, 315 pregnant women with BMI>50 kg/m2 were identified using the Australasian Mater-
nity Outcomes Surveillance System.
Table 1 presents the characteristics and outcomes of the pooled cohorts of extremely obese
women (BMI>50 kg/m2) and comparison women (BMI<50 kg/m2) from UKOSS and AMOSS.
The median BMI was 53 kg/m2 (interquartile range (IQR) 51–56) in the extremely obese cohort
while the median BMI in the comparison cohort was 25 kg/m2 (IQR 22–28). The extremely obese
women were on average slightly older (31yrs vs. 30yrs, p<0.001) compared to comparison
women. A significantly higher proportion of extremely obese women had antihypertensive medi-
cations prior to pregnancy (6.3% vs. 0.5%); multiparity (67.1% vs. 57.9%); a history of previous
caesarean deliveries (21.8% vs. 13.5%); and pre-existing diabetes (7.9% vs. 1.2%).
Maternal outcomes
Table 2 shows current pregnancy characteristics and maternal outcomes in the extremely
obese cohort and the comparison group. Pregnant women with BMI>50 had higher odds of
hypertensive disorders during pregnancy, pregnancy induced hypertension and preeclampsia
compared to comparison women.
Pregnant women with BMI>50 had significantly higher odds of caesarean delivery and
induction of labour than the comparison group. Extremely obese women who had a caesarean
delivery, had a significantly higher odds of wound infection than the comparison group.
Extremely obese women had a nine-fold increase in the odds of thrombotic events compared
to those with a BMI<50 during pregnancy.
Perinatal outcomes
Twelve of the infants born to women in the extremely obese cohort died in the early neonatal
period or were stillborn (Table 3). Maternal BMI>50 during pregnancy was associated with
raised odds of perinatal death (uOR: 1.78 (95%:0.75–4.25)) and stillbirth (uOR: 1.50 (95%CI:
0.58–3.90)), although these associations were not statistically significant. Although there was a
Maternal and perinatal outcomes of extreme maternal obesity
PLOS ONE | https://doi.org/10.1371/journal.pone.0211278 February 4, 2019 4 / 11
raised odds of preterm birth, very preterm birth and congenital abnormality none of these
associations were statistically significant (Table 3).
Multivariable analysis
Maternal outcomes. There were no maternal deaths. Pregnant women with BMI>50 had
over a four fold increase in the odds of preeclampsia and eclampsia (adjusted odds ratio
(aOR): 4.88 (95%CI: 3.11–7.65)) and nine fold increase in the odds of pregnancy induced
hypertension (aOR: 9.09 (95%CI:5.75–14.38) compared to pregnant women with BMI<50,
after adjusting for smoking status, pre-existing diabetes and parity (Table 4). Pregnant women
with BMI>50 had over two times the odds of having a caesarean delivery (aOR: 2.77 (95%CI:
2.31–3.32)) compared to those with a BMI<50, after adjusting for previous caesarean delivery
Table 1. Sociodemographic characteristics and previous medical problems in pregnant women with BMI>50 and comparison women with BMI<50 during
pregnancy.
Number (%) of obese women
(n = 932)
Number (%)
of comparison women (n = 1232)
P-value
Sociodemographic characteristics
Age Mean (Std) 31 (5.7) 30 (6.0) <0.001
BMI at booking Median (IQR) 53 (51–56) 24.5 (21.8–28.4) <0.001
Smoking status Never/ex-smoker 684 (73.4) 945 (76.7)
Smoked during pregnancy 230 (24.7) 246 (20) 0.014
Missing 18 (1.9) 41 (3.3)
Known previous medical history
Known cardiac disease None 921 (98.8) 1,212 (98.4)
Yes 7 (0.8) 8 (0.6) 0.786
Missing 4 (0.4) 12 (1)
Known renal disease None 919 (98.6) 1,213 (98.5)
Yes 9 (1) 7 (0.6) 0.290
Missing 4 (0.4) 12 (1)
Known mental health issues None 855 (91.7) 1,155 (93.8)
Yes 73 (7.8) 65 (5.3) 0.017
Missing 4 (0.4) 12 (1)
Known asthma None 818 (87.8) 1,159 (94.1)
Yes 110 (11.8) 62 (5) <0.001
Missing 4 (0.4) 11 (0.9)
Previous caesarean deliveries None 419 (45) 542 (44)
Yes 203 (21.8) 166 (13.5) <0.001
Not applicable 306 (32.8) 519 (42.1)
Missing 4 (0.4) 5 (0.4)
Parity Nulliparous 306 (32.8) 519 (42.1) <0.001
Multiparous 625 (67.1) 713 (57.9)
Missing 1 (0.1) 0 (0)
Hypertension prior to pregnancy None 870 (93.3) 1,220 (99)
Yes 59 (6.3) 6 (0.5) <0.001
Missing 3 (0.3) 6 (0.5)
Pre-existing diabetes None 858 (92.1) 1,211 (98.3)
Yes 74 (7.9) 15 (1.2) <0.001
Missing 0 (0) 6 (0.5)
Insulin dependent Yes 21 (2.3) 5 (0.4) 0.062
https://doi.org/10.1371/journal.pone.0211278.t001
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and previous pregnancy problems (Table 4). Pregnant women with BMI>50 who had a caesar-
ean delivery had seven times the odds of having a wound infection compared to comparison
women (aOR: 7.25, 95%CI: 3.28–16.07), after controlling for pre-existing diabetes.
Perinatal outcomes. Infants born to pregnant women with BMI>50 were eight times
more likely to have macrosomia (aOR: 8.05 (95%CI: 4.70–13.78)) than infants born to women
with BMI<50 after adjusting for gestational age at delivery (Table 3). There was a two times
(aOR: 2.03 (95% CI: 1.13–3.66)) higher odds of a low Apgar score at 5 minutes among the
babies of pregnant women with BMI>50 after adjusting for gestational age at delivery. There
was raised odds of an infant respiratory problem/respiratory distress syndrome (aOR: 2.00
(0.91–4.42)), however this was not statistically significant.
The sensitivity analyses shown in models B (which restricted the comparison to women
with BMI <30) and C (complete case analysis model) did not materially change the results.
Discussion
Maternal BMI>50 during pregnancy was associated with an increased likelihood of a number
of adverse maternal and perinatal outcomes including hypertensive disorders, macrosomia, a









Unadjusted Odds Ratios 95% Confidence intervals P-value
Multiple pregnancy No 908 (97.4) 1,211 (98.3) 1
Yes 24 (2.6) 20 (1.6) 1.60 (0.88–2.92) 0.124
Missing 0 (0) 1 (0.1)
Hypertensive disorder during pregnancy No 708 (76) 1,167 (94.7) 1
Yes 216 (23.2) 52 (4.2) 6.85 (4.99–9.40) <0.001
Missing 8 (0.9) 13 (1.1)
Pregnancy induced hypertension No 796 (85.4) 1,195 (97) 1
Yes 128 (13.7) 24 (1.9) 8.01 (5.13–12.50) <0.001
Missing 8 (0.9) 13 (1.1)
Preeclampsia and eclampsia No 836 (89.7) 1,191 (96.7) 1
Yes 88 (9.4) 28 (2.3) 4.48 (2.99–6.91) <0.001
Missing 8 (0.9) 13 (1.1)
Induction of labour No 575 (61.7) 955 (77.5) 1
Yes 343 (36.8) 271 (22) 2.10 (1.74–2.54) <0.001
Missing 14 (1.5) 6 (0.5)
Caesarean delivery No 446 (47.9) 900 (73.1) 1
Yes 473 (50.8) 332 (26.9) 2.87 (2.40–3.44) <0.001
Missing 13 (1.4) 0 (0)
Wound infection in those with caesarean delivery No 391 (42) 310 (25.2) 1
Yes 71 (7.6) 7 (0.6) 8.04 (3.65–17.73) <0.001
N/A 459 (49.2) 900 (73.1)
Missing 11 (1.2) 15 (1.2)
Thrombotic event No 918 (98.5) 1,231 (99.9) 1
Yes 7 (0.8) 1 (0.1) 9.39 (1.15–76.43) 0.036
Missing 7 (0.8) 0 (0)
Complete case analysis used for the unadjusted analysis.
https://doi.org/10.1371/journal.pone.0211278.t002
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low Apgar score at 5 minutes and caesarean birth. Extreme maternal obesity in both countries
was associated with increased odds of potentially preventable outcomes such as thrombotic
events and wound infection. This study has shown the combination of two national studies
increased the statistical power of testing and precision to estimate the incidence of more com-
mon maternal and perinatal outcomes in extremely obese women.
Strengths and limitations
This study has shown that it is feasible to combine data from two nations examining a rare
exposure in pregnancy. Using similar case notification systems and data collection forms.
Combining the data increased the sample size and hence the precision of the estimates of
effect. The examination of the upper end of the BMI continuum has shown that women with
an extremely high BMI have a higher risk of adverse maternal and perinatal outcomes than
those with a lower BMI.
The combining of two independent studies from different maternal populations had a
number of limitations. Firstly, the definition of extreme obesity was not identical which led to
the exclusion of two women with a BMI = 50 from the dataset. In addition, some variables








Unadjusted Odds Ratios 95% Confidence intervals P-value
Perinatal death� No 927 (98.5) 1,239 (99.2) 1
Yes 12 (1.3) 9 (0.8) 1.78 (0.75–4.25) 0.192
Missing 2 (0.2) 1 0.1
Still birth�24weeks gestation No 930 (98.8) 1,239 (99.2) 1
Yes 9 (1) 8 (0.6) 1.50 (0.58–3.90) 0.407
Missing 2 (0.2) 2 (0.2)
Preterm birth No 831 (89.2) 1,135 (91.5) 1
Yes 97 (10.4) 103 (8.3) 1.29 (0.93–1.78) 0.126
Missing 4 (0.4) 3 (0.2)
Very preterm birth No 915 (98.2) 1,229 (99) 1
Yes 13 (1.4) 9 (0.7) 1.94 (0.76–4.94) 0.164
Missing 4 (0.4) 3 (0.2)
Birthweight Mean (StD) 3613.2 (24.1) 3,342 (17.82) -
Macrosomia (>4500 grams) No 844 (90.6) 1,221 (98.4) 1
Yes 86 (9.2) 17 (1.4) 7.32 (4.32–12.40) <0.001
Missing 2 (0.2) 3 (0.2)
Congenital anomaly No 904 (97) 1,207 (97.3)
Yes 16 (1.7) 22 (1.8) 0.97 (0.50–1.88) 0.931
Missing 12 (1.3) 12 (1.0)
Infant respiratory problem No 906 (97.2) 1,221 (98.4)
Yes 21 (2.3) 13 (1.0) 2.18 (1.02–4.66) 0.045
Missing 5 (0.5) 7 (0.6)
5-min Apgar score <7 No 883 (94.7) 1,201 (96.8)
Yes 27 (2.9) 19 (1.5) 1.93 (1.07–3.50) 0.03
Missing 22 (2.4) 21 (1.7)
�Fetal deaths that have occurred after�24 weeks of gestational age and before 7 completed days after birth. Complete case analysis used for the unadjusted analysis.
https://doi.org/10.1371/journal.pone.0211278.t003
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identified from the literature were not available in both datasets or were collected using differ-
ent definitions, which led to an analysis based on only those variables that existed in both data-
sets and could be harmonised. As a result, important variables such as socioeconomic status,
postpartum haemorrhage and gestational diabetes were not available for analysis. In addition,
we did not have access to ethnicity from Australia. Data on outcomes that are not collected
uniformly across countries need to be interpreted with caution. Furthermore, the comparison
population was collected from consultant led units so these women may have had higher rates
of complications than women who deliver in midwife led units. The study comparison group
was representative of the general population; however, it may underestimate the risk of out-
comes when compared to a group with a normal BMI. Gestational weight gain was not col-
lected, however, if a pregnant women presented with BMI>50 kg/m2 at any gestational age
she would have been eligible for inclusion in the study.
Table 4. Adjusted odds ratio (aOR) associated with maternal BMI>50 during pregnancy.
Model A Model B Model C
Maternal outcomes aOR 95% CI P-value aOR 95% CI P-value aOR 95% CI P-value
Preeclampsia & eclampsia
BMI<50 kg/m2 1 1 1
BMI>50 kg/m2 4.88 (3.11–7.65) <0.001 6.53 (3.76–11.34) <0.001 4.81 (3.06–7.55) <0.001
Pregnancy induced hypertension
BMI<50 kg/m2 1 1
BMI>50 kg/m2 9.09 (5.75–14.38) <0.001 8.45 (5.07–14.09) <0.001 8.61 (5.44–13.64) <0.001
Caesarean delivery
BMI<50 kg/m2 1 1 1
BMI>50 kg/m2 2.77 (2.31–3.32) <0.001 3.34 (2.65–4.21) <0.001 3.07 (2.49–3.79) <0.001
Induction of labour
BMI<50 kg/m2 1 1 1
BMI>50 kg/m2 2.45 (2.00–2.99) <0.001 2.64 (2.12–3.29) <0.001 2.48 (2.02–3.03) <0.001
Wound infection
BMI<50 kg/m2 1 1 1
BMI>50 kg/m2 7.25 (3.28–16.07) <0.001 11.72 (3.63–37.80) <0.001 7.25 (3.28–16.07) <0.001
Perinatal outcomes
Macrosomia�
BMI<50 kg/m2 1 1 1
BMI>50 kg/m2 8.05 (4.70–13.78) <0.001 9.75 (5.06–18.81) <0.001 8.05 (4.70–13.78) <0.001
5-min Apgar score <7�
BMI<50 kg/m2 1 1 1
BMI>50 kg/m2 2.03 (1.13–3.66) 0.02 2.13 (1.12–4.07) 0.02 2.03 (1.13–3.66) 0.02
Respiratory problem�
BMI<50 kg/m2 1 1 1
BMI>50 kg/m2 2.00 (0.91–4.42) 0.09 1.77 (0.76–4.13) 0.18 2.00 (0.91–4.42) 0.09
Model A: proxy variable for missing values. Model B: comparison group BMI <30. Model C: complete case analysis. Pre-eclampsia and pregnancy induced
hypertension: adjusted for smoking status, pre-existing diabetes and parity. Caesarean delivery: adjusted for previous caesarean delivery, previous pregnancy problems.
Wound infection: adjusted for pre-existing diabetes. Macrosomia: adjusted for gestational age. Apgar < 7 @ 5min: adjusted for gestational age and parity. Respiratory
problem: gestational age at delivery.
�Calculated using robust standard errors.
https://doi.org/10.1371/journal.pone.0211278.t004
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Interpretation
There was an increase in the odds ratios for most of the outcomes investigated suggesting
that a causal relationship may exist between perinatal mortality and extreme obesity. How-
ever, this study did not have the power to exclude the role of chance for a substantial num-
ber of outcomes and these tended, unsurprisingly, to be the rarer outcomes. Therefore,
future international studies of rare complications of pregnancy in combination with rare
outcomes will need to aim to include more countries to increase the size of the study
population
A recent review of reviews suggested an association between maternal obesity BMI� 30kg/
m2 and wound infection after a caesarean delivery [13] which is consistent with our data for
pregnant women with BMI>50. UK national guidance recommends that prophylactic antibi-
otics should be routinely administered to all women who undergo a caesarean delivery [14].
Future research should consider the dose women with BMI>50 receive as there is currently lit-
tle evidence examining weight appropriate antibiotic dosages [15].
Hypertensive disorders of pregnancy
There is considerable evidence showing an association between maternal obesity and an
increased risk of hypertensive disorders [13, 16]; this relationship has also been shown in preg-
nant women with BMI�50 [7, 17, 18]. With larger numbers this analysis was able to more pre-
cisely estimate the magnitude of the association, showing that pregnant women with BMI>50
had over six times the odds of preeclampsia compared to a non-obese population with the 95%
CI ranging from a fourfold to a 11 fold increased risk.
Mode of delivery
The results of this study are consistent with the finding from a review which showed obese
women were at increased risk of caesarean delivery [19] and with other studies of women with
BMI>50 [7, 17, 18]. Despite an increased risk of regional anaesthetic failure and increased dif-
ficulty in intubation at surgical interventions, women with BMI>50 were more likely to be
delivered by caesarean section [20]. There are many clinical factors which may lead to the deci-
sion to deliver an obese women by caesarean section, some of these include: increased risk of
shoulder dystocia, failure to progress, infant distress and previous caesarean deliveries [19].
Added to this, as particularly pertinent in women with BMI>50, is the fear of anaesthetic com-
plications if emergency delivery is required. Appropriate planning of mode of delivery is indi-
cated for pregnant women with BMI>50 as additional resources and equipment may be
indicated. As a result, the availability of facilities to ensure safe delivery if surgical problems
arise should be factored into the decision surrounding mode of delivery.
Perinatal outcomes
Meta-analysis of observational data has shown that a high pre-pregnancy body mass index is
associated with infant macrosomia [21]. In particular, there is a positive relationship between
increasing maternal body mass index and higher infant birthweight. The findings of this study
are consistent with both the wider literature on obesity in pregnancy [21] and maternal BMI
�50 [8, 22]. Similarly, the association between maternal obesity with poor infant condition
immediately after birth has been supported by both a wider maternal obesity review [23] and
studies of pregnant women with BMI>50 [17].
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Conclusions
The findings showed that pregnant women with BMI>50 have a higher risk of poor maternal
outcomes and some perinatal outcomes than those with a lower BMI. Obese women appear to
have a higher risk of preventable outcomes such as thrombotic events and wound infection,
which highlights that there needs to be a more proactive approach to management. Further
guidance to aid prevention amongst this patient group is indicated, including assessment of
weight when determining therapeutic drug dosages.
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